Clinical Trial Update: Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the anti-tumor activity and tolerability of faslodex alone or in combination with arimidex in postmenopausal women with primary breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-08-16